TELA Bio (TELA) Competitors $1.70 +0.12 (+7.59%) Closing price 04:00 PM EasternExtended Trading$1.67 -0.03 (-1.76%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TELA vs. NNOX, NYXH, SKIN, OM, BWAY, SMTI, SGHT, MGRM, CVRX, and SIShould you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include Nano-X Imaging (NNOX), Nyxoah (NYXH), Beauty Health (SKIN), Outset Medical (OM), Brainsway (BWAY), Sanara MedTech (SMTI), Sight Sciences (SGHT), Monogram Orthopaedics (MGRM), CVRx (CVRX), and Shoulder Innovations (SI). These companies are all part of the "medical equipment" industry. TELA Bio vs. Its Competitors Nano-X Imaging Nyxoah Beauty Health Outset Medical Brainsway Sanara MedTech Sight Sciences Monogram Orthopaedics CVRx Shoulder Innovations TELA Bio (NASDAQ:TELA) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability. Do institutionals & insiders have more ownership in TELA or NNOX? 94.4% of TELA Bio shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 4.7% of TELA Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media favor TELA or NNOX? In the previous week, Nano-X Imaging had 10 more articles in the media than TELA Bio. MarketBeat recorded 18 mentions for Nano-X Imaging and 8 mentions for TELA Bio. Nano-X Imaging's average media sentiment score of -0.02 beat TELA Bio's score of -0.24 indicating that Nano-X Imaging is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Nano-X Imaging 2 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Which has more volatility and risk, TELA or NNOX? TELA Bio has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Comparatively, Nano-X Imaging has a beta of 1.95, suggesting that its share price is 95% more volatile than the S&P 500. Which has higher valuation and earnings, TELA or NNOX? TELA Bio has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTELA Bio$69.30M0.97-$37.84M-$1.12-1.52Nano-X Imaging$11.28M21.82-$53.52M-$0.90-4.73 Is TELA or NNOX more profitable? TELA Bio has a net margin of -54.12% compared to Nano-X Imaging's net margin of -468.29%. Nano-X Imaging's return on equity of -32.09% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets TELA Bio-54.12% -329.48% -57.34% Nano-X Imaging -468.29%-32.09%-28.73% Do analysts recommend TELA or NNOX? TELA Bio currently has a consensus target price of $4.50, suggesting a potential upside of 164.71%. Nano-X Imaging has a consensus target price of $8.50, suggesting a potential upside of 99.53%. Given TELA Bio's higher probable upside, equities analysts plainly believe TELA Bio is more favorable than Nano-X Imaging.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TELA Bio 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Nano-X Imaging 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50 SummaryNano-X Imaging beats TELA Bio on 10 of the 17 factors compared between the two stocks. Get TELA Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TELA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TELA vs. The Competition Export to ExcelMetricTELA BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$67.35M$3.12B$5.70B$9.79BDividend YieldN/A2.21%3.77%4.10%P/E Ratio-1.5220.7630.8625.25Price / Sales0.97231.85403.9088.50Price / CashN/A41.5625.2228.45Price / Book2.369.759.516.00Net Income-$37.84M-$54.74M$3.26B$265.34M7 Day Performance-8.60%8.09%4.49%2.81%1 Month Performance-20.19%7.70%5.18%1.50%1 Year Performance-45.34%18.13%31.98%25.46% TELA Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TELATELA Bio2.7352 of 5 stars$1.70+7.6%$4.50+164.7%-49.2%$67.35M$69.30M-1.52120Earnings ReportNNOXNano-X Imaging2.127 of 5 stars$4.72+1.4%$9.50+101.5%-38.7%$268.67M$11.28M-5.24190Earnings ReportAnalyst RevisionNYXHNyxoah2.8007 of 5 stars$7.02-5.4%$15.00+113.7%-20.1%$252.73M$4.89M-3.30110News CoverageEarnings ReportShort Interest ↑Gap UpHigh Trading VolumeSKINBeauty Health1.0929 of 5 stars$2.21+16.9%$2.63+18.8%+54.6%$238.13M$334.30M-7.891,030High Trading VolumeOMOutset Medical1.3489 of 5 stars$12.43-2.9%$24.67+98.4%+33.4%$227.41M$113.69M-0.61520BWAYBrainsway3.2728 of 5 stars$12.10+2.9%$14.25+17.8%+64.9%$222.24M$41.02M60.50120Trending NewsEarnings ReportAnalyst UpgradeShort Interest ↓Analyst RevisionGap UpHigh Trading VolumeSMTISanara MedTech1.9987 of 5 stars$26.86+8.3%$49.50+84.3%-8.5%$220.42M$86.67M-20.0460News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionGap UpSGHTSight Sciences1.4857 of 5 stars$4.12-2.8%$4.27+3.6%-30.6%$219.19M$79.87M-4.29210MGRMMonogram Orthopaedics1.7758 of 5 stars$5.38-0.4%$5.40+0.4%+89.0%$192.71M$370K-11.9628Earnings ReportShort Interest ↓CVRXCVRx2.4603 of 5 stars$7.51+3.7%$14.00+86.4%-12.9%$189.34M$51.29M-3.58160Positive NewsSIShoulder InnovationsN/A$12.08-2.7%N/AN/A$188.99MN/A-0.4061Analyst Upgrade Related Companies and Tools Related Companies Nano-X Imaging Competitors Nyxoah Competitors Beauty Health Competitors Outset Medical Competitors Brainsway Competitors Sanara MedTech Competitors Sight Sciences Competitors Monogram Orthopaedics Competitors CVRx Competitors Shoulder Innovations Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TELA) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TELA Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TELA Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access